You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

Litigation Details for TAWIL v. FINANCIAL INDUSTRY REGULATORY AUTHORITY (N.D. Fla. 2022)

✉ Email this page to a colleague

« Back to Dashboard

TAWIL v. FINANCIAL INDUSTRY REGULATORY AUTHORITY (N.D. Fla. 2022)

Docket	⤷ Sign Up	Date Filed	2022-12-12
Court	District Court, N.D. Florida	Date Terminated	2023-07-26
Cause	12:22 Securities Fraud	Assigned To	Robert Lewis Hinkle
Jury Demand	None	Referred To	Martin A. Fitzpatrick
Parties	FINANCIAL INDUSTRY REGULATORY AUTHORITY
Patents	10,335,223
Attorneys	ROZA M TAWIL
Firms	Erchid Law Firm Tampa Fl
Link to Docket	External link to docket

Biologic Drugs cited in TAWIL v. FINANCIAL INDUSTRY REGULATORY AUTHORITY

The biologic drug covered by the patent cited in this case is ⤷ Sign Up .

Details for TAWIL v. FINANCIAL INDUSTRY REGULATORY AUTHORITY (N.D. Fla. 2022)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2022-12-14	6		$ 12,491,191 $ 10,335,223 Disallowed…and CNPC and is a technologist with an extensive patent portfolio. Since retiring from Shell in 2016, Mr	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.